Your email has been successfully added to our mailing list.

×
0.0460704607046071 0.0509485094850949 0.0092140921409215 0.0108401084010842 0.013550135501355 0.0162601626016261 0.0113821138211383 0.0216802168021681
Stock impact report

Intercept Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Intercept Pharmaceuticals, Inc. (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations
Company Research Source: GlobeNewswire
Worldwide Ocaliva® net sales of $88.6 million, representing 8% growth over the prior year quarter Nearing completion of new REGENERATE data analyses; planning for potential pre-submission meeting with FDA in June Continue to expect topline results from Phase 3 REVERSE study in compensated cirrhosis due to NASH in Q3 Advanz Pharma to acquire Ocaliva® (obeticholic acid) in PBC markets outside the U.S. for up to $450MM, including $405MM upfront and an additional $45MM in contingent payments Company to host conference call today at 8:30 a.m. ET MORRISTOWN, N.J, May 06, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced its financial results for the quarter ended March 31, 2022. “Our team made considerable progress in the first quarter of this year as we continued to drive the growth of Ocaliva in PB Show less Read more
Impact Snapshot
Event Time:
ICPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ICPT alerts
Opt-in for
ICPT alerts

from News Quantified
Opt-in for
ICPT alerts

from News Quantified